• DOI:10.1101/791871
Corpus ID: 208603663

Microglial depletion with CSF1R inhibitor during chronic phase of experimental traumatic brain injury reduces neurodegeneration and neurological deficits

@article{Henry2019MicroglialDW,
  title={Microglial depletion with CSF1R inhibitor during chronic phase of experimental traumatic brain injury reduces neurodegeneration and neurological deficits},
  author={R. Henry and R. Ritzel and James P. Barrett and Sarah J. Doran and Y. Jiao and J. Leach and Gregory L Szeto and B. Stoica and A. Faden and D. Loane},
  journal={bioRxiv},
  year={2019}
}

R. Henry, R. Ritzel, +7 authors D. Loane

Published 2019

Biology, Medicine

bioRxiv

Chronic neuroinflammation with sustained microglial activation occurs following moderate-to-severe traumatic brain injury (TBI) and is believed to contribute to subsequent neurodegeneration and neurological deficits. Microglia, the primary innate immune cells in brain, are dependent on colony stimulating factor 1 receptor (CSF1R) signaling for their survival. In this translational study, we examined the effects of delayed depletion and subsequent repopulation of microglia on chronic… CONTINUE READING

View via Publisher

mdsoar.org

Save to Library

Create Alert

Cite

Launch Research Feed